Journals / Haydarpaşa Numune Medical Journal / 2022 / Cilt: 62 - Sayı: 2

Determination of Pro-BNP and Troponin I Levels for ShortTerm Mortality Prediction in Ischemic Stroke Patients who did not Undergo Revascularization

Pages
134–139
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The overall median pro-BNP level of all patients was 799.00 pg/ml (IQR: 220.00–2818.25).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Emergency departments (EDs) are the first place to start treatment for most stroke patients.
📊
Key Findings & Data:Our objective, in this study, is to research short-term (14th day) mortality prediction of serum Troponin I (TnI) and pro-brain natriuretic peptide (BNP) levels.
💡
Conclusion & Impact:The overall median pro-BNP level of all patients was 799.00 pg/ml (IQR: 220.00–2818.25).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Emergency departments (EDs) are the first place to start treatment for most stroke patients. Prognozing patients for planning and proper management of the therapies have an important place in approaching stroke patients. Many studies have been carried out with serum biomarkers especially in terms of prognosis stroke. Our objective, in this study, is to research short-term (14th day) mortality prediction of serum Troponin I (TnI) and pro-brain natriuretic peptide (BNP) levels. Methods: This was a prospective and observational prognostic test study. All consecutive patients admitted to the ED with the onset of symptoms in the past 24 h and diagnosed with the first episode of acute ischemic stroke were included in the study. A total of 121 subjects were included in the study. On admission, pro-BNP and TnI were collected from all subjects. On the 14th day of admission, patients were checked for mortality. Results: Of 121 patients, 14 (11.5%) had a mortal outcome at the end of the 14th day. The overall median pro-BNP level of all patients was 799.00 pg/ml (IQR: 220.00–2818.25). The median pro-BNP level of the non-survivor group was significantly higher than that of the survivor group (p:0.030). However, there was no significant difference between the TnI levels of the mortality groups. The optimal cutoff value of serum pro-BNP levels as an indicator of mortality on the 14th day was estimated to be 509 pg/ml (sensitivity: 85.7%, specificity: 49.5%, and AUC: 0.68 [95% CI, 0.59–0.769]). Discussion and Conclusion: Various biomarkers are investigated for prediction of mortality in ischemic stroke patient. According to our study, elevated pro-BNP values are associated with mortality. Further study with larger patient cohorts can be studied regarding the relationship between these threshold, in terms of predicting the mortality, in a more comprehensive study, as well as using subgroup and underlying conditions.

🔖

Cite This Article

AKOĞLU, H., ALTINOK, A. D., ONUR, Ö., ÖZPOLAT, Ç., AYDIN, N. (2022). Determination of Pro-BNP and Troponin I Levels for ShortTerm Mortality Prediction in Ischemic Stroke Patients who did not Undergo Revascularization. Haydarpaşa Numune Medical Journal, Cilt: 62 - Sayı: 2, 134–139. https://ajindex.com/articles/535835

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics-2018 update: A report from the American heart association. Circulation 2018;137:e67–e492
  2. Manea MM, Comsa M, Minca A, Dragos D, Popa C. Brain-heart axis--Review Article. J Med Life 2015;8:266–71
  3. Sandhu R, Aronow WS, Rajdev A, Sukhija R, Amin H, D'aquila K, et al. Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol 2008;102:632–4
  4. Jensen JK, Kristensen SR, Bak S, Atar D, Høilund-Carlsen PF, Mickley H. Frequency and significance of troponin T elevation in acute ischemic stroke. Am J Cardiol 2007;99:108–12
  5. Faiz KW, Thommessen B, Einvik G, Omland T, Rønning OM. Prognostic value of high-sensitivity cardiac troponin T in acute ischemic stroke. J Stroke Cerebrovasc Dis 2014;23:241–8
  6. Faiz KW, Thommessen B, Einvik G, Brekke PH, Omland T, Rønning OM. Determinants of high sensitivity cardiac troponin T elevation in acute ischemic stroke. BMC Neurol 2014;14:96
  7. Azzazy HM, Christenson RH. B-type natriuretic peptide: Physiologic role and assay characteristics. Heart Fail Rev 2003;8:315–20
  8. Sayan S, Kotan D. Levels of brain natriuretic peptide as a marker for the diagnosis and prognosis of acute ischemic stroke. Arch Med Sci Atheroscler Dis 2016;1:e16–e22
  9. Shibazaki K, Kimura K, Okada Y, Iguchi Y, Uemura J, Terasawa Y, et al. Plasma brain natriuretic peptide as an independent predictor of in-hospital mortality after acute ischemic stroke. Intern Med 2009;48:1601–6
  10. Jensen JK, Atar D, Kristensen SR, Mickley H, Januzzi JL Jr. Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke. Am J Cardiol 2009;104:287–91
  11. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015;351:h5527
  12. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:517–84
  13. Müller C, Kuster G, Büttner HJ, Buser P. B-type natriuretic peptide--current use in the diagnosis and management of heart failure. Herz 2003;28:374–9. [Article in German] 14. Chimowitz MI, Mancini GB. Asymptom